Lai Leng Yew
Director/Board Member at GDS GLOBAL LIMITED
Lai Leng Yew active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GDS GLOBAL LIMITED | Director/Board Member | 24/10/2023 | - |
| Independent Dir/Board Member | 24/10/2023 | - | |
| NeoAsia (S) Pte Ltd. | Corporate Officer/Principal | 30/09/2023 | - |
Career history of Lai Leng Yew
Former positions of Lai Leng Yew
| Companies | Position | Start | End |
|---|---|---|---|
Axcynsis Therapeutics Pte Ltd.
 Axcynsis Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Axcynsis Therapeutics Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company focuses on developing antibody-x conjugate (AXC) therapies to revolutionize cancer treatments. The company is leveraging proprietary technologies to develop a robust pipeline of AXC candidates with the potential to address unmet medical needs for new treatment options. The company was founded in 2022 by Zou Bin, who has been the CEO since 2022. | Corporate Officer/Principal | 31/01/2023 | 30/06/2023 |
Zuellig Pharma Asia Pacific Ltd.
 Zuellig Pharma Asia Pacific Ltd. Medical DistributorsDistribution Services Zuellig Pharma Asia Pacific Ltd. engages in the manufacture and distribution of pharmaceutical and healthcare products. The company is headquartered in Hong Kong. | Corporate Officer/Principal | 31/12/2010 | 31/12/2017 |
Training of Lai Leng Yew
| University of Keele | Undergraduate Degree |
Statistics
International
| Singapore | 4 |
| Hong Kong | 2 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GDS GLOBAL LIMITED | Producer Manufacturing |
| Private companies | 3 |
|---|---|
| NeoAsia (S) Pte Ltd. | |
Axcynsis Therapeutics Pte Ltd.
Axcynsis Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Axcynsis Therapeutics Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company focuses on developing antibody-x conjugate (AXC) therapies to revolutionize cancer treatments. The company is leveraging proprietary technologies to develop a robust pipeline of AXC candidates with the potential to address unmet medical needs for new treatment options. The company was founded in 2022 by Zou Bin, who has been the CEO since 2022. | Commercial Services |
Zuellig Pharma Asia Pacific Ltd.
Zuellig Pharma Asia Pacific Ltd. Medical DistributorsDistribution Services Zuellig Pharma Asia Pacific Ltd. engages in the manufacture and distribution of pharmaceutical and healthcare products. The company is headquartered in Hong Kong. | Distribution Services |
- Stock Market
- Insiders
- Lai Leng Yew
- Experience
